Q4 2022 Holdings
Filed 2023-02-14 | 33 holdings | $148.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $44.4M | 3,000,000 | 29.9% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $42.2M | 2,305,558 | 28.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $25.3M | 4,886,616 | 17.0% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $12.0M | 2,485,638 | 8.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $11.2M | 701,402 | 7.5% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $9.7M | 1,642,210 | 6.5% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $2.9M | 1,937,207 | 2.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $125.7K | 4,831,307 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $106.5K | 3,577,267 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $90.5K | 8,300,000 | 0.1% |
| Natera Inc(NTRA) | COM | 632307104 | $56.2K | 1,400,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $50.8K | 8,663,673 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $41.7K | 3,915,000 | 0.0% |
| Pharvaris N V(PHVS) | COM | N69605108 | $35.8K | 3,180,601 | 0.0% |
| Cara Therapeutics Inc(CARAEUR) | COM | 140755109 | $29.0K | 2,696,030 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $25.8K | 2,364,410 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $24.6K | 10,003,573 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $22.7K | 3,777,308 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $20.0K | 1,822,883 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $18.0K | 11,622,598 | 0.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $16.8K | 3,130,422 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $13.9K | 1,921,790 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $13.2K | 1,408,901 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $12.1K | 12,202,510 | 0.0% |
| Rapid Micro Biosystems Inc(RPID) | CLASS A COM | 75340L104 | $9.5K | 8,434,560 | 0.0% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $7.6K | 2,124,694 | 0.0% |
| Xilio Therapeutics Inc(XLO) | COM | 98422T100 | $7.5K | 2,805,413 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $5.7K | 1,431,058 | 0.0% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $5.0K | 1,151,657 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $3.6K | 2,000,000 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $2.5K | 8,891,758 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.4K | 5,347,689 | 0.0% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $86 | 100,000 | 0.0% |